RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Khosrow Kashfi to Neoplasms

This is a "connection" page, showing publications Khosrow Kashfi has written about Neoplasms.
Connection Strength

6.165
  1. Dos Reis RA, Sarkar I, Rodrigues MG, Matson JB, Seabra AB, Kashfi K. NO- and H2S- releasing nanomaterials: A crosstalk signaling pathway in cancer. Nitric Oxide. 2024 Oct 01; 151:17-30.
    View in: PubMed
    Score: 0.407
  2. Oza PP, Kashfi K. The Triple Crown: NO, CO, and H2S in cancer cell biology. Pharmacol Ther. 2023 09; 249:108502.
    View in: PubMed
    Score: 0.378
  3. Oza PP, Kashfi K. The evolving landscape of PCSK9 inhibition in cancer. Eur J Pharmacol. 2023 Jun 15; 949:175721.
    View in: PubMed
    Score: 0.370
  4. Alimardan Z, Abbasi M, Hasanzadeh F, Aghaei M, Khodarahmi G, Kashfi K. Heat shock proteins and cancer: The FoxM1 connection. Biochem Pharmacol. 2023 05; 211:115505.
    View in: PubMed
    Score: 0.368
  5. Kashfi K. Dedication to Dr. Larry K. Keefer at the Sixth International Workshop on Nitric Oxide in Cancer and Beyond. Crit Rev Oncog. 2023; 28(1):xi-xviii.
    View in: PubMed
    Score: 0.363
  6. Kashfi K. Fifty Years of Diazeniumdiolate Research: A Tribute to Dr. Larry K. Keefer. Crit Rev Oncog. 2023; 28(1):47-55.
    View in: PubMed
    Score: 0.363
  7. Kolawole OR, Kashfi K. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase. Int J Mol Sci. 2022 Jan 27; 23(3).
    View in: PubMed
    Score: 0.341
  8. Kashfi K, Kannikal J, Nath N. Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO. Cells. 2021 11 16; 10(11).
    View in: PubMed
    Score: 0.336
  9. Patel KK, Kashfi K. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochem Pharmacol. 2022 02; 196:114654.
    View in: PubMed
    Score: 0.326
  10. Kashfi K. Nitric oxide in cancer and beyond. Biochem Pharmacol. 2020 06; 176:114006.
    View in: PubMed
    Score: 0.302
  11. Nath N, Kashfi K. Tumor associated macrophages and 'NO'. Biochem Pharmacol. 2020 06; 176:113899.
    View in: PubMed
    Score: 0.299
  12. Bahadoran Z, Mirmiran P, Ghasemi A, Kashfi K. Type 2 Diabetes and Cancer: The Nitric Oxide Connection. Crit Rev Oncog. 2019; 24(3):235-242.
    View in: PubMed
    Score: 0.275
  13. Kashfi K, Rosen CL, Aslan M. Obesity, Type-2 Diabetes and Cancer: Mechanistic Insights. Crit Rev Oncog. 2019; 24(3):285-305.
    View in: PubMed
    Score: 0.275
  14. Kashfi K. The dichotomous role of H2S in cancer cell biology? D?j? vu all over again. Biochem Pharmacol. 2018 03; 149:205-223.
    View in: PubMed
    Score: 0.259
  15. Kashfi K. Anti-cancer activity of new designer hydrogen sulfide-donating hybrids. Antioxid Redox Signal. 2014 Feb 10; 20(5):831-46.
    View in: PubMed
    Score: 0.187
  16. Kashfi K. Dysfunctional cell signaling dynamics in oncology: diagnostic, prognostic and treatment opportunities. Biochem Pharmacol. 2013 Mar 01; 85(5):595-596.
    View in: PubMed
    Score: 0.182
  17. Chattopadhyay M, Kodela R, Nath N, Street CR, Vel?zquez-Mart?nez CA, Boring D, Kashfi K. Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo. Biochem Pharmacol. 2012 Mar 15; 83(6):733-40.
    View in: PubMed
    Score: 0.169
  18. Kashfi K. Anti-inflammatory agents as cancer therapeutics. Adv Pharmacol. 2009; 57:31-89.
    View in: PubMed
    Score: 0.147
  19. Kashfi K, Rigas B. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. Biochem Pharmacol. 2005 Oct 01; 70(7):969-86.
    View in: PubMed
    Score: 0.110
  20. Kashfi K, Rigas B. Molecular targets of nitric-oxide-donating aspirin in cancer. Biochem Soc Trans. 2005 Aug; 33(Pt 4):701-4.
    View in: PubMed
    Score: 0.109
  21. Rigas B, Kashfi K. Cancer prevention: a new era beyond cyclooxygenase-2. J Pharmacol Exp Ther. 2005 Jul; 314(1):1-8.
    View in: PubMed
    Score: 0.106
  22. Rigas B, Kashfi K. Nitric-oxide-donating NSAIDs as agents for cancer prevention. Trends Mol Med. 2004 Jul; 10(7):324-30.
    View in: PubMed
    Score: 0.101
  23. Aghaz F, Asadi Z, Sajadimajd S, Kashfi K, Arkan E, Rahimi Z. Codelivery of resveratrol melatonin utilizing pH responsive sericin based nanocarriers inhibits the proliferation of breast cancer cell line at the different pH. Sci Rep. 2023 07 08; 13(1):11090.
    View in: PubMed
    Score: 0.094
  24. Abbasi M, Mahboubi-Rabbani M, Kashfi K, Sadeghi-Aliabadi H. Prediction of dual NF-?B/I?B inhibitors using an integrative in-silico approaches. J Biomol Struct Dyn. 2023; 41(23):14164-14178.
    View in: PubMed
    Score: 0.092
  25. Kashfi K. The role of hydrogen sulfide in health and disease. Biochem Pharmacol. 2018 03; 149:1-4.
    View in: PubMed
    Score: 0.065
  26. Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol. 2015 Dec; 6:334-343.
    View in: PubMed
    Score: 0.055
  27. Kashfi K, Olson KR. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem Pharmacol. 2013 Mar 01; 85(5):689-703.
    View in: PubMed
    Score: 0.045
  28. Kodela R, Chattopadhyay M, Nath N, Cieciura LZ, Pospishill L, Boring D, Crowell JA, Kashfi K. Synthesis and biological activity of acetyl-protected hydroxybenzyl diethyl phosphates (EHBP) as potential chemotherapeutic agents. Bioorg Med Chem Lett. 2011 Dec 01; 21(23):7146-50.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support